Structure | Chemical Name | CAS | MF |
|
(2S,3R)-3-Bromo-2-ethoxytetrahydro-2H-pyran
|
|
C7H13BrO2
|
|
(2S,6'R)-7-Bromo-2',4,6-trimethoxy-6'-methylspiro[benzofuran-2(3H),1'-[2]cyclohexene]-3,4'-dione
|
17793-98-5
|
|
|
1-[(1S,3R)-3-Bromo-1,2,2-trimethylcyclopentyl]-4-methylbenzene
|
57794-64-6
|
C15H21Br
|
|
(S)-2-[[(2R)-(3β-Bromotetrahydrofuran)-2α-yl]oxy]propionic acid methyl ester
|
|
|
|
(2S)-2β-[(R)-Bromochloromethyl]-2,6,6-trimethylcycloheptanone
|
|
|
|
SRC-IIHD
|
|
|
|
SRC HUMAN
|
|
|
|
SRC(HUMANENDOGENOUS)(ONCOGENEPROTEIN),RABBITANTI-
|
|
|
|
(2S,4R)-4-cinnaMylpyrrolidine-2-carboxylic acid hydrochloride
|
1049740-87-5
|
C14H18ClNO2
|
|
(2S,4R)-4-cinnaMylpyrrolidine-2-carboxylic acid
|
1049980-72-4
|
C14H17NO2
|
|
Alisol A
|
19885-10-0
|
C30H50O5
|
|
(1S,2R)-cis-2-AMino-1,2,3,4-tetrahydro-1-naphthol hydrochloride
|
29365-58-0
|
C10H14ClNO
|
|
(1S,2R)-cis-2-(Boc-aMino)-1,2,3,4-tetrahydro-1-naphthol
|
904316-34-3
|
C15H21NO3
|
|
(1S,3R)-CIS-3-CARBOMETHOXY CYCLOPENTANE-1-CARBOXYLIC ACID
|
96443-42-4
|
C8H12O4
|
|
(1S,2R)-CIS-2-AMINO-1-CYCLOHEXANE-CARBOXYLIC ACID
|
|
C7H13NO2
|
|
(-)-(1S 5R)-CIS-BICYCLO[3.2.0]HEPT-2-EN-
|
71155-04-9
|
C7H8O
|
|
(1S,2R)-(-)-CIS-2-BENZAMIDOCYCLOHEXANEMETHANOL
|
|
C14H19NO2
|
|
(1S,2R)-(+)-CIS-2-BENZAMIDOCYCLOHEXANECARBOXYLIC ACID
|
|
C14H17NO3
|
|
(1S,4R)-CIS-4-ACETOXY-2-CYCLOPENEN-1-OL
|
|
C7H10O3
|
|
(2S,3R)-CIS-3-METHYL-L-PROLINE ETHYL ESTER
|
186586-71-0
|
C8H15NO2
|
|
(1S,2R)-(-)-cis-1-Amino-2-indanol
|
126456-43-7
|
C9H11NO
|
|
(1S,2R)-CIS-2-AMINO-1-CYCLOHEXANECARBOXYLIC ACID ETHYL ESTER HYDROCHLORIDE
|
|
C9H18ClNO2
|
|
(-)-(1S,2R)-CIS-3,4-DICHLORO-N-METHYL-N-[2-(1-PYRROLIDINYL)-CYCLOHEXYL]-BENZENEACETAMIDE TARTRATE
|
|
C23H32Cl2N2O7
|
|
(2S,3R)-CIS-3-METHYL-L-PROLINE METHYL ESTER
|
180978-01-2
|
C7H13NO2
|
|
(4S,5R)-(-)-CIS-4,5-DIPHENYL-2-OXAZOLIDINONE
|
23204-70-8
|
C15H13NO2
|
|
(-)-(1S,5R)-CIS-BICYCLO[3.2.0]HEPT-2-EN-6-ONE
|
|
C7H8O
|
|
(2S,4R)-cis-4-Hydroxypiperidine-2-carboxylic acid
|
1844-40-2
|
C6H11NO3
|
|
(1S,2R)-CIS-5-METHOXY-1-METHYL-2-(DIMETHYLAMINO)TETRALIN HYDROCHLORIDE
|
|
C14H22ClNO
|
|
SP VSV-G EXPRESSION VECTOR
|
|
|
|
SRC Kinase Substrate, amide
|
|
|
|
SRC Kinase Substrate
|
|
|
|
SRC KINASE INHIBITOR II
|
|
|
|
Src kinase (Csk) peptide substrate
|
|
C76H111N15O17
|
|
(2S,3R)-2-[(D-Alanyl)amino]-3-[[(1S)-2-(1H-imidazol-4-yl)-1-carboxyethyl]amino]butyric acid
|
|
C13H21N5O5
|
|
(20S,24R)-Dammar-25-ene-3α,12β,20,24-tetrol
|
|
|
|
(2S,3R)-2-[(D-Asparaginyl)amino]-3-[[(1S)-2-(1H-imidazol-4-yl)-1-carboxyethyl]amino]butyric acid
|
|
C14H22N6O6
|
|
Src-like adapter protein
|
|
|
|
(2S,6R,7β)-7-Butyl-2-pentyl-1-azaspiro[5.5]undecane
|
63983-65-3
|
C19H37N
|
|
(4S,10R)-10-Butyl-5,9,10,11-tetrahydro-10-hydroxy-4-pentyl-1H-cyclonona[1,2-c:5,6-c']difuran-1,3,6,8(4H)-tetrone
|
39012-16-3
|
C22H28O7
|
|
(5α,8α,18S,19R)-7β-Butoxy-18,19-epoxycleroda-3,12,14-triene-2α,6α,18,19-tetrol 6,18,19-triacetate
|
|
|
|
(5α,8α,18S,19R)-7β-Butoxy-18,19-epoxycleroda-3,12,14-triene-2α,6α,18,19-tetrol 2,18,19-triacetate
|
|
|
|
S-[(2R)-3-Butoxy-3-oxo-2-[(trifluoroacetyl)amino]propyl]-N-trifluoroacetyl-L-homocysteine butyl ester
|
55518-00-8
|
C19H28F6N2O6S
|
|
(5α,8α,18S,19R)-19-Butoxy-2α-methoxy-18,19-epoxycleroda-3,12,14-triene-6α,18-diol diacetate
|
|
|
|
(5α,8α,18S,19R)-7β-Butoxy-18,19-epoxy-2α-methoxycleroda-3,12,14-triene-18,19-diol diacetate
|
|
|
|
(2S,3R)-2-Butyl-1-methoxy-3-methylbicyclo[3.2.2]non-6-en-2-ol
|
|
C15H26O2
|
|
(5α,8α,18S,19R)-7β-Butoxy-18,19-epoxycleroda-3,12,14-triene-2α,18,19-triol 18,19-diacetate
|
|
|
|
(2S,3R)-3-Butyl-5-[(2-propenyl)oxy]-2,3-dihydrobenzofuran-2-acetic acid methyl ester
|
|
C18H24O4
|
|
(2S,3R)-1,2,3,4-Butanetetrol 2,3-diacetate 1,4-dibenzoate
|
|
C22H22O8
|
|
(2S,3R)-2-[(butylsulfonyl)amino]-3-hydroxybutanoic acid
|
|
C8H17NO5S
|
|
(4S,5R)-(-)-3-BUTOXYCARBONYL-METHYL-4,5-DIPHENYL-2-OXAZOLIDINONE
|
|
C21H23NO4
|
|
(2S,5R)-6-[[2-[(4-butyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-pheny l-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2 -carboxylic acid
|
65125-89-5
|
C25H31N5O7S
|
|
(1S,2R)-2-({2-[4-(butyrylamino)benzoyl]hydrazino}carbonyl)cyclohexanecarboxylic acid
|
|
C19H25N3O5
|
|
SRC N2
|
|
|
|
SRC N1
|
|
|
|
Src N1, Human, Recombinant
|
|
|
|
SRCN1, HUMAN
|
|
|
|
(8S,9R)-3-Dehydro-11-hydrocinchonan-9-ol
|
6536-33-0
|
C19H22N2O
|
|
Dirithromycin
|
62013-04-1
|
C42H78N2O14
|
|
Src peptide
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-18-methylicosyl]-17-methyl-4-octadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-14-methylhexadecyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-20-methyldocosyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentadecyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotricosyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxo-13-methyltetradecyl]-15-methyl-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentadecyl]-4-tetradecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentacosyl]-15-methyl-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-12-methyltetradecyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-12-methyltetradecyl]-14-methyl-4-hexadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxodocosyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxohexadecyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxohenicosyl]-17-methyl-4-octadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxodocosyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxoicosyl]-14-methyl-4-hexadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxo-22-methyltricosyl]-4-tetradecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-18-methylicosyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxo-13-methyltetradecyl]-4-tetradecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotetracosyl]-4-tetradecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxoicosyl]-17-methyl-4-octadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxohenicosyl]-15-methyl-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentacosyl]-14-methyl-4-hexadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotetracosyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotetracosyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentadecyl]-17-methyl-4-octadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotricosyl]-14-methyl-4-hexadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentadecyl]-15-methyl-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotetracosyl]-15-methyl-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxoicosyl]-15-methyl-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxo-13-methyltetradecyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxodocosyl]-4-tetradecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxo-22-methyltricosyl]-14-methyl-4-hexadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-20-methyldocosyl]-14-methyl-4-hexadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxoicosyl]-4-tetradecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxodocosyl]-17-methyl-4-octadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxohexadecyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotricosyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentacosyl]-4-heptadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxopentacosyl]-14-methyl 4-pentadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(R)-2-hydroxy-1-oxotricosyl]-17-methyl-4-octadecen-3-ol
|
|
|
|
(2S,3R)-1-(β-D-Galactopyranosyloxy)-2-[(2R)-2-hydroxy-1-oxo-20-methyldocosyl]-17-methyl-4-octadecen-3-ol
|
|
|